A phase 1b trial of the combination of an all-oral regimen of capecitabine and erlotinib in advanced non-small cell lung cancer in Caucasian patients

被引：0
|
作者：
Rajiv Kumar
Shir Kiong Lu
Anna Minchom
Adam Sharp
Michael Davidson
Ranga Gunapala
Timothy A. Yap
Jaishree Bhosle
Sanjay Popat
Mary E. R. O’Brien
机构：
[1] The Royal Marsden NHS Foundation Trust,Department of Medicine
[2] The Institute of Cancer Research & The Royal Marsden NHS Foundation Trust,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2016年 / 77卷
关键词：
Non-small cell lung cancer; Adenocarcinoma; Capecitabine; Erlotinib; Phase 1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：375 / 383
页数：8
相关论文
共 50 条
  • [41] CORRELATIVE ANALYSIS OF CIRCULATING BIOMARKERS FROM A PHASE 1B/2 TRIAL OF CABOZANTINIB (C) WITH OR WITHOUT ERLOTINIB (E) IN PATIENTS (PTS) WITH ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC)
    Padda, Sukhmani K.
    Rosenberg-Hasson, Yael
    Neal, Joel W.
    Gettinger, Scott N.
    Engelman, Jeffrey A.
    Jaenne, Pasi A.
    West, Howard L.
    Subramaniam, Deepa
    Leach, Joseph W.
    Lara, Primo N.
    Wax, Michael B.
    Wakelee, Heather A.
    Clary, Douglas O.
    Zhou, Lisa
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1072 - S1073
  • [42] PHASE I AND PHARMACOKINETIC STUDY OF ERLOTINIB ADMINISTERED IN COMBINATION WITH AMRUBICIN IN PATIENTS WITH PREVIOUSLY TREATED, ADVANCED NON-SMALL CELL LUNG CANCER
    Otani, Sakiko
    Hamada, Akinobu
    Sasaki, Jiichiro
    Yamamoto, Michiko
    Ryuge, Shinichiro
    Takakura, Akira
    Fukui, Tomoya
    Yokoba, Masanori
    Mitsufuji, Hisashi
    Toyooka, Issei
    Maki, Sachiyo
    Kubota, Masaru
    Katagiri, Masato
    Saito, Hideyuki
    Masuda, Noriyuki
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1165 - S1165
  • [43] Phase I and Pharmacokinetic Study of Erlotinib Administered in Combination With Amrubicin in Patients With Previously Treated, Advanced Non-small Cell Lung Cancer
    Otani, Sakiko
    Hamada, Akinobu
    Sasaki, Jiichiro
    Wada, Mayuko
    Yamamoto, Michiko
    Ryuge, Shinichiro
    Takakura, Akira
    Fukui, Tomoya
    Yokoba, Masanori
    Mitsufuji, Hisashi
    Toyooka, Issei
    Maki, Sachiyo
    Kimura, Michiko
    Hayashi, Nobuatsu
    Ishihara, Mikiko
    Kasajima, Masashi
    Hiyoshi, Yasuhiro
    Katono, Ken
    Asakuma, Maiko
    Igawa, Satoshi
    Kubota, Masaru
    Katagiri, Masato
    Saito, Hideyuki
    Masuda, Noriyuki
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2015, 38 (04): : 405 - 410
  • [44] A multicenter phase II study of sorafenib in combination with erlotinib in patients with advanced non-small cell lung cancer (KCSG-0806)
    Lim, Sun Min
    Cho, Byoung Chul
    Kim, Sang-We
    Kang, Seok Yun
    Heo, Dae Seog
    Kim, Heung Tae
    Lee, Dae Ho
    Kim, Dong-Wan
    Jung, Minkyu
    Choi, Jin-Hyuk
    Shim, Hyo Sup
    Choi, Jong Rak
    Kim, Joo-Hang
    LUNG CANCER, 2016, 93 : 1 - 8
  • [45] Comparison of gefitinib and erlotinib for Korean patients with advanced non-small cell lung cancer
    Lee, Jin Hwa
    Jo, You Ri
    Park, Hye Sung
    Ryu, Yon Ju
    Chun, Eun Mi
    Chang, Jung Hyun
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S692 - S692
  • [46] Population pharmacokinetics of erlotinib in Japanese patients with advanced non-small cell lung cancer
    Emoto-Yamamoto, Y.
    Iida, S.
    Kawanishi, T.
    Fukuoka, M.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2015, 40 (02) : 232 - 239
  • [47] Sunitinib in Combination With Erlotinib for the Treatment of Advanced/Metastatic Non-small Cell Lung Cancer (NSCLC): a Phase III Study
    Govindan, R.
    Krzakowski, M. J.
    Szczesna, A.
    Strausz, J.
    Makhson, A. N.
    Reck, M.
    Tye, L.
    Zhang, K.
    Chao, R. C.
    Scagliotti, G. V.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S557 - S557
  • [48] Gefitinib or Erlotinib in the Treatment of Advanced Non-small Cell Lung Cancer
    Shao, Yu-Yun
    Lin, Chia-Chi
    Yang, Chih-Hsin
    DISCOVERY MEDICINE, 2010, 9 (49) : 538 - 545
  • [49] Randomized Phase II Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild-Type Non-Small Cell Lung Cancer
    Sequist, Lecia, V
    Gray, Jhanelle Elaine
    Harb, Wael A.
    Lopez-Chavez, Ariel
    Doebele, Robert C.
    Modiano, Manuel R.
    Jackman, David Michael
    Baggstrom, Maria Quintos
    Atmaca, Akin
    Felip, Enriqueta
    Provencio, Mariano
    Cobo, Manuel
    Adiwijaya, Bambang
    Kuesters, Geoffrey
    Kamoun, Walid S.
    Andreas, Karen
    Pipas, J. Marc
    Santillana, Sergio
    Cho, Byoung Chul
    Park, Keunchil
    Shepherd, Frances A.
    ONCOLOGIST, 2019, 24 (08): : 1095 - 1102
  • [50] Randomized Phase 2 Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild-Type Non-Small Cell Lung Cancer
    Sequist, L.
    Gray, J.
    Harb, W.
    Doebele, R.
    Modiano, M.
    Jackman, D.
    Baggstrom, M.
    Atmaca, A.
    Felip, E.
    Provencio, M.
    Cobo Dols, M.
    Adiwijaya, B.
    Kuesters, G.
    Kamoun, W.
    Andreas, K.
    Pipas, J.
    Santillana, S.
    Cho, B. C.
    Park, K.
    Shepherd, F.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S596 - S596
12345